Atossa Therapeutics
ATOS
#9116
Rank
NZ$0.20 B
Marketcap
NZ$1.57
Share price
7.61%
Change (1 day)
-27.61%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -NZ$48.33 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$43.83 Million, an increase over its 2023 earnings that were of -NZ$51.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$48.33 Million10.25%
2024 -NZ$43.83 Million-15.25%
2023 -NZ$51.72 Million11.62%
2022 -NZ$46.34 Million30.84%
2021 -NZ$35.42 Million15.58%
2020 -NZ$30.64 Million3.41%
2019 -NZ$29.63 Million51.16%
2018 -NZ$19.6 Million40.41%
2017 -NZ$13.96 Million27.54%
2016 -NZ$10.95 Million-47.49%
2015 -NZ$20.85 Million-17.25%
2014 -NZ$25.19 Million35.91%
2013 -NZ$18.54 Million112.3%
2012 -NZ$8.73 Million46.53%
2011 -NZ$5.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$55.67 B-112,907.30%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.29 B-4,742.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.21 B-4,581.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-NZ$13.48 Million-72.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$71.62 M-245.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$0.19 Billion 280.29%๐Ÿ‡บ๐Ÿ‡ธ USA